Last updated: July 21, 2021
Sponsor: I.M. Sechenov First Moscow State Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Prostate Cancer
Prostate Cancer, Early, Recurrent
Urologic Cancer
Treatment
N/AClinical Study ID
NCT04506710
RSCS-L0838
Ages > 18 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Histologically confirmed prostate cancer;
- PSA up to 10 ng / ml; Gleason (3 + 3) = 6 (ISUP 1); the stage of the tumor T2a (low-risk according to the D'Amico scale);
Exclusion
Exclusion Criteria:
- Failure of the recording device;
- Unsatisfactory audio quality.
Study Design
Total Participants: 50
Study Start date:
August 01, 2019
Estimated Completion Date:
January 31, 2022
Connect with a study center
Institute for Urology and Reproductive Health, Sechenov University.
Moscow, 119991
Russian FederationActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.